Skip to content
NewsBlazeIN – Lifestyle
Author:
Vigo Consulting Limited
Data on Anti-4CB1 Published in Molecular Cancer Therapeutics Journal
August 20, 2026
Elevara Medicines Appoints Biotech Veteran as CEO
July 14, 2026
Elevara Medicines Doses First Patient in Phase 2b START-SYNERGY Trial of ELV001 in Rheumatoid Arthritis Patients with Incomplete Response to TNFi
March 16, 2026